Michael J. O'Grady, Adam Retterath, Barry Keenan D., Natalie Kurtz, Martin Cantwell, Glenn Spital, Michael N. Kremliovsky, Anirban Roy, Elizabeth A. Davis, Timothy W Jones, Trang T Ly
The second and, arguably, more promising therapeutic approach to Î2-cell replacement is a closedloop artificial pancreas incorporating a continuous glucose sensor, insulin pump, and control algorithm. The Medtronic Portable Glucose Control System (PGCS) is a portable, automated, closed-loop device consisting of a BlackBerry Storm smartphone (Research in Motion, Waterloo, ON, Canada), an unmodified Medtronic Paradigm Veo insulin pump, two MiniLink REAL-Time Transmitters (Medtronic Minimed, Northridge, CA) modified to transmit at 1-min rather than 5 -min intervals, two Enlite glucose sensors (Medtronic Minimed), and a Medtronic custom-built radiofrequency translator, as illustrated in Fig. 1 .
© 2001-2024 Fundación Dialnet · Todos los derechos reservados